Literature DB >> 28791613

Oleic acid Enhances Dengue Virus But Not Dengue Virus-Like Particle Production from Mammalian Cells.

Suwipa Ramphan1, Sathiporn Suksathan1, Nitwara Wikan1, Puey Ounjai2, Kanpong Boonthaworn2, Poramate Rimthong3, Tapanee Kanjanapruthipong3, Suchin Worawichawong3, Anan Jongkaewwattana4, Nuttaporn Wongsiriroj1, Duncan R Smith5.   

Abstract

Despite the recent introduction of a commercial vaccine, the mosquito-transmitted dengue virus is still a worldwide public health problem. Based on the live attenuated vaccine strategy, the commercial vaccine has a less than optimal protective profile. Virus-like particles (VLPs) offer an attractive alternate vaccination strategy due to the effectively native presentation of epitopes in the absence of any infectious genetic material. However, the production of amounts of VLP in a platform that can support commercial development remains a major obstacle. This study generated two DENV 2 VLPs [codon-optimized and chimeric DENV/Japanese encephalitis virus (JEV)] and directly compared yields of these constructs by western blotting and dot blot hybridization. The effect of oleic acid supplementation, a process known to increase DENV production in natural infection, was also investigated. Results showed that the chimeric construct gave a two- to threefold higher yield than the codon-optimized construct and that while oleic acid increased DENV virion production in natural infection, it inhibited VLP production. These results suggest that further optimization of DENV VLP expression is possible, but it will require more understanding of how native DENV infection remodels the host cell machinery.

Entities:  

Keywords:  Dengue virus; Electron microscopy; Expression; Oleic acid; Virus-like particle

Mesh:

Substances:

Year:  2017        PMID: 28791613     DOI: 10.1007/s12033-017-0029-4

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  37 in total

1.  Generation and preclinical immunogenicity study of dengue type 2 virus-like particles derived from stably transfected mosquito cells.

Authors:  Amporn Suphatrakul; Thippawan Yasanga; Poonsook Keelapang; Rungtawan Sriburi; Thaneeya Roytrakul; Rojjanaporn Pulmanausahakul; Utaiwan Utaipat; Yanee Kawilapan; Chunya Puttikhunt; Watchara Kasinrerk; Sutee Yoksan; Prasert Auewarakul; Prida Malasit; Nicha Charoensri; Nopporn Sittisombut
Journal:  Vaccine       Date:  2015-09-14       Impact factor: 3.641

2.  Association of lipid profile alterations with severe forms of dengue in humans.

Authors:  Anyelo Durán; Rafaela Carrero; Belkis Parra; Andrea González; Lineth Delgado; Jesús Mosquera; Nereida Valero
Journal:  Arch Virol       Date:  2015-05-05       Impact factor: 2.574

Review 3.  Waiting in the wings: The potential of mosquito transmitted flaviviruses to emerge.

Authors:  Duncan R Smith
Journal:  Crit Rev Microbiol       Date:  2016-11-01       Impact factor: 7.624

Review 4.  Exploitation of cellular pathways by Dengue virus.

Authors:  Wolfgang Fischl; Ralf Bartenschlager
Journal:  Curr Opin Microbiol       Date:  2011-07-27       Impact factor: 7.934

5.  Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence.

Authors:  E A Henchal; M K Gentry; J M McCown; W E Brandt
Journal:  Am J Trop Med Hyg       Date:  1982-07       Impact factor: 2.345

6.  Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice.

Authors:  Shuo Zhang; Mifang Liang; Wen Gu; Chuan Li; Fang Miao; Xiaofang Wang; Cong Jin; Li Zhang; Fushun Zhang; Quanfu Zhang; Lifang Jiang; Mengfeng Li; Dexin Li
Journal:  Virol J       Date:  2011-06-30       Impact factor: 4.099

7.  Dengue virus infection perturbs lipid homeostasis in infected mosquito cells.

Authors:  Rushika Perera; Catherine Riley; Giorgis Isaac; Amber S Hopf-Jannasch; Ronald J Moore; Karl W Weitz; Ljiljana Pasa-Tolic; Thomas O Metz; Jiri Adamec; Richard J Kuhn
Journal:  PLoS Pathog       Date:  2012-03-22       Impact factor: 6.823

8.  Involvement of fatty acid synthase in dengue virus infection.

Authors:  Natthida Tongluan; Suwipa Ramphan; Phitchayapak Wintachai; Janthima Jaresitthikunchai; Sarawut Khongwichit; Nitwara Wikan; Supoth Rajakam; Sutee Yoksan; Nuttaporn Wongsiriroj; Sittiruk Roytrakul; Duncan R Smith
Journal:  Virol J       Date:  2017-02-13       Impact factor: 4.099

9.  Human Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P) regulates cytoplasmic lipid droplet abundance: A potential target for indirect-acting anti-dengue virus agents.

Authors:  Anastasia Hyrina; Fanrui Meng; Steven J McArthur; Sharlene Eivemark; Ivan R Nabi; François Jean
Journal:  PLoS One       Date:  2017-03-24       Impact factor: 3.240

10.  Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins.

Authors:  Pei-Gang Wang; Mateusz Kudelko; Joanne Lo; Lewis Yu Lam Siu; Kevin Tsz Hin Kwok; Martin Sachse; John M Nicholls; Roberto Bruzzone; Ralf M Altmeyer; Béatrice Nal
Journal:  PLoS One       Date:  2009-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.